Pages that link to "Q35833324"
Jump to navigation
Jump to search
The following pages link to Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells (Q35833324):
Displaying 43 items.
- Latency reversal and viral clearance to cure HIV-1. (Q30248766) (← links)
- Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System (Q33592852) (← links)
- Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection (Q33620546) (← links)
- HIV-1 Latency and Eradication: Past, Present and Future (Q37505823) (← links)
- Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies (Q37621530) (← links)
- Landscape review of current HIV 'kick and kill' cure research - some kicking, not enough killing. (Q38636019) (← links)
- IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis (Q38720858) (← links)
- Use of broadly neutralizing antibodies for HIV-1 prevention (Q38764543) (← links)
- Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir (Q38777005) (← links)
- Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy (Q38971085) (← links)
- Current views on HIV-1 latency, persistence, and cure. (Q38973362) (← links)
- Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection (Q38977425) (← links)
- HIV antibodies for treatment of HIV infection (Q39108716) (← links)
- One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells. (Q40074629) (← links)
- HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversal (Q40080802) (← links)
- Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells (Q40084640) (← links)
- Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies (Q40366328) (← links)
- Beyond Viral Neutralization (Q40373085) (← links)
- Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques (Q41933491) (← links)
- Patterns of conserved gp120 epitope presentation on attached HIV-1 virions (Q47109778) (← links)
- Cell and Gene Therapy for HIV Cure (Q47236016) (← links)
- The Antiviral Immune Response and Its Impact on the HIV-1 Reservoir (Q47600020) (← links)
- Immune Interventions to Eliminate the HIV Reservoir (Q47600062) (← links)
- Exosomal Tat protein activates latent HIV-1 in primary, resting CD4+ T lymphocytes. (Q52606459) (← links)
- Targeting the Latent Reservoir for HIV-1. (Q54210140) (← links)
- Antiviral Activity of HIV gp120 Targeting Bispecific T Cell Engager (BiTE®) Antibody Constructs. (Q54222576) (← links)
- Current Strategies for Elimination of HIV-1 Latent Reservoirs Using Chemical Compounds Targeting Host and Viral Factors (Q57795262) (← links)
- Bispecific antibodies: potential immunotherapies for HIV treatment (Q57808733) (← links)
- Barriers and strategies to achieve a cure for HIV (Q58003747) (← links)
- Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies (Q58724935) (← links)
- Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction (Q60046873) (← links)
- Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases (Q60938672) (← links)
- Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies (Q64083383) (← links)
- Engineering therapeutic antibodies to combat infectious diseases (Q89132174) (← links)
- Novel vaccines: Technology and development (Q89407998) (← links)
- Pathways towards human immunodeficiency virus elimination (Q89957160) (← links)
- Design and Production of Bispecific Antibodies (Q90212096) (← links)
- Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline (Q90315006) (← links)
- Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes (Q90594140) (← links)
- Multispecific, Multivalent Antibody-Based Molecules Engineered on the DART® and TRIDENTTM Platforms (Q91957257) (← links)
- Have Cells Harboring the HIV Reservoir Been Immunoedited? (Q92857802) (← links)
- Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART® Molecules (Q94561594) (← links)
- Pharmaceutical Approaches to HIV Treatment and Prevention (Q98292337) (← links)